[1] JAGSI R,MASON G,OVERMOYER BA,et al.Inflammatory breast cancer defined:proposed common diagnostic criteria to guide treatment and research [J].Breast Cancer Research and Treatment,2022,192(2):235-243.
[2] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA-A Cancer Journal for Clinicians,2021,71(3):209-249.
[3] DASTJERD NT,VALIBEIK A,RAHIMI MONFARED S,et al.Gene therapy:A promising approach for breast cancer treatment [J].Cell Biochemistryand Function,2022,40(1):28-48.
[4] CALI DAYLAN AE,LEONE JP.Targeted therapies for breast cancer brain metastases [J].Clinical Breast Cancer,2021,21(4):263-270.
[5] FIGUEIREDO R,ADAO R,LEITE-MOREIRA AF,et al.Candidate microRNAs as prognostic biomarkers in heart failure:A systematic review [J].Revista Portuguesade Cardiologia,2022,41(10):865-885.
[6] DIENER C,KELLER A,MEESE E.Emerging concepts of miRNA therapeutics:from cells to clinic [J].Trends in Genetics,2022,38(6):613-626.
[7] PUPPO M,VALLURU MK,CLEZARDIN P.MicroRNAs and their roles in breast cancer bone metastasis [J].Current Osteoporosis Reports,2021,19(3):256-263.
[8] BAHREINI F,RAYZAN E,REZAEI N.microRNA-related single-nucleotide polymorphisms and breast cancer [J].Journal of Cellular Physiology,2021,236(3):1593-1605.
[9] SEMPERE LF,AZMI AS,MOORE A.microRNA-based diagnostic and therapeutic applications in cancer medicine [J].Wiley Interdisciplinary Reviews-RNA,2021,12(6):e1662-e1716.
[10] KANCHAN RK,SIDDIQUI JA,MAHAPATRA S,et al.MicroRNAs orchestrate pathophysiology of breast cancer brain metastasis:advances in therapy [J].Molecular Cancer,2020,19(1):29-45.
[11] DWIVEDI S,PAREEK P,VISHNOI JR,et al.Downregulation of miRNA-21 and cancer stem cells after chemotherapy results in better outcome in breast cancer patients [J].World Journal of Stem Cells,2022,14(4):310-313.
[12] XU W,SONG C,WANG X,et al.Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis [J].Aging(Albany NY),2021,13(1):228-240.
[13] YANG X,YANG J,TANG Y,et al.miR-4295 promotes the malignant progression of gastric cancer via targeting PTEN [J].Combinatorial Chemistry High Throughput Screening,2022,25(11):1897-1906.
[14] YAN X,WANG T,WANG J.Circ_0016760 acts as a sponge of microRNA-4295 to enhance E2F transcription factor 3 expression and facilitates cell proliferation and glycolysis in non-small cell lung cancer [J].Cancer Biotherapy and Radiopharmaceuticals,2022,37(2):147-158.
[15] MELHUISH TA,KOWALCZYK I,MANUKYAN A,et al.Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression [J].Biochimica et Biophysica Acta-Gene Regulatory Mechanisms,2018,1861(11):983-995.
[16] YU J,ZHAO S,SU Z,et al.Whole exome analysis reveals the genomic profiling related to chemo-resistance in Chinese population with limited-disease small cell lung cancer [J].Cancer Medicine,2023,12(2):1035-1050.
[17] HAMIDI AA,ZANGOUE M,KASHANI D,et al.MicroRNA-217:a therapeutic and diagnostic tumor marker [J].Expert Review of Molecular Diagnostics,2022,22(1):61-76.
[18] TARIGHATI E,KEIVAN H,MAHANI H.A review of prognostic and predictive biomarkers in breast cancer [J].Clinical and Experimental Medicine,2023,23(1):1-16.
[19] MALTONI R,BALZI W,ROSSI T,et al.Appropriateness and economic analysis of conventional circulating biomarkers assessment in early breast cancer:A real-world e from the E.Pic.A Study [J].Current Oncology,2022,29(2):433-438.